Regulating internet pharmacies at the European level is necessary

Posted by healthblogger on 02/10/09

It would be a serious mistake not have an EU-wide regulatory framework for internet pharmacies.  Not achieving one would be just more evidence of the politics that infects all discussions of cross-border healthcare to the detriment of the patient and health consumer.  Illegal drugs, fake drugs, reimported drugs, counterfeit drugs, substandard drugs, legitimate drugs — [...]

New directions for a productive and innovative European biopharma industry

Posted by healthblogger on 01/09/09

Recent research suggests that the European pharmaceutical industry is more productive than the US one.  Euractive reports on this here: article-184974.
A few things to consider.  Light’s work is a reanalysis of existing data.  His conclusions are based on using the head-office of the company discovering the drug as determining the country of origin.  He is [...]

Innovative medicines: it is about the patient, stupid!

Posted by healthblogger on 21/12/07

The Innovative Medicines Initiative seeks to put right the chaotic treatment of pharmaceutical innovation by EU member states, and will likely fail.  The goose that lays golden eggs of medical innovation is cooked to death by member state medicines policies.
Increasing the speed of product development will come to a grinding halt as member states inconsistently [...]

Advertisement